VOYA Investment Management’s Halozyme HALO Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2.38M Sell
36,818
-50
-0.1% -$3.52K ﹤0.01% 1109
2025
Q4
$2.48M Sell
36,868
-9,382
-20% -$631K ﹤0.01% 1126
2025
Q3
$3.39M Sell
46,250
-69,808
-60% -$4.64M ﹤0.01% 1027
2025
Q2
$6.04M Sell
116,058
-354,125
-75% -$20.2M 0.01% 889
2025
Q1
$30M Buy
470,183
+28,915
+7% +$1.68M 0.03% 416
2024
Q4
$21.1M Buy
441,268
+57,150
+15% +$2.93M 0.02% 530
2024
Q3
$22M Buy
384,118
+22,535
+6% +$1.29M 0.02% 522
2024
Q2
$18.9M Buy
361,583
+92,437
+34% +$4.05M 0.02% 562
2024
Q1
$10.9M Sell
269,146
-37
-0% -$1.39K 0.01% 728
2023
Q4
$9.95M Buy
269,183
+24,830
+10% +$935K 0.01% 744
2023
Q3
$9.33M Sell
244,353
-164,019
-40% -$6.72M 0.01% 720
2023
Q2
$14.7M Buy
408,372
+174,225
+74% +$5.94M 0.02% 609
2023
Q1
$8.94M Sell
234,147
-40,708
-15% -$1.91M 0.01% 768
2022
Q4
$15.6M Sell
274,855
-18,373
-6% -$941K 0.02% 593
2022
Q3
$11.6M Buy
293,228
+183,676
+168% +$8.12M 0.01% 656
2022
Q2
$4.82M Sell
109,552
-143,078
-57% -$6.19M 0.01% 758
2022
Q1
$10.1M Sell
252,630
-7,222
-3% -$257K 0.02% 618
2021
Q4
$10.4M Sell
259,852
-188,658
-42% -$7.04M 0.02% 588
2021
Q3
$18.2M Buy
448,510
+213,975
+91% +$8.95M 0.04% 362
2021
Q2
$10.7M Buy
234,535
+16,503
+8% +$730K 0.02% 586
2021
Q1
$9.09M Sell
218,032
-23,225
-10% -$1.06M 0.02% 614
2020
Q4
$10.3M Buy
241,257
+194,415
+415% +$6.99M 0.02% 562
2020
Q3
$1.23M Hold
46,842
﹤0.01% 1196
2020
Q2
$1.26M Sell
46,842
-21,725
-32% -$490K ﹤0.01% 1181
2020
Q1
$1.23M Sell
68,567
-1,747
-2% -$33.2K ﹤0.01% 1136
2019
Q4
$1.25M Buy
70,314
+17,265
+33% +$299K ﹤0.01% 1331
2019
Q3
$823K Hold
53,049
﹤0.01% 1442
2019
Q2
$911K Buy
53,049
+1,467
+3% +$23.7K ﹤0.01% 1403
2019
Q1
$830K Hold
51,582
﹤0.01% 1466
2018
Q4
$755K Buy
51,582
+1,748
+4% +$27.9K ﹤0.01% 1465
2018
Q3
$905K Hold
49,834
﹤0.01% 1467
2018
Q2
$841K Sell
49,834
-3,200
-6% -$60.5K ﹤0.01% 1481
2018
Q1
$1.04M Hold
53,034
﹤0.01% 1360
2017
Q4
$1.07M Hold
53,034
﹤0.01% 1383
2017
Q3
$921K Buy
53,034
+2,306
+5% +$31.2K ﹤0.01% 1483
2017
Q2
$650K Sell
50,728
-1,500,555
-97% -$20M ﹤0.01% 1664
2017
Q1
$20.1M Sell
1,551,283
-50,909
-3% -$644K 0.05% 384
2016
Q4
$15.8M Sell
1,602,192
-103,585
-6% -$1.13M 0.04% 429
2016
Q3
$20.6K Sell
1,705,777
-170,095
-9% -$1.74M 0.04% 344
2016
Q2
$16.2M Buy
1,875,872
+416,476
+29% +$4.11M 0.04% 421
2016
Q1
$13.8M Buy
1,459,396
+616,975
+73% +$5.81M 0.03% 451
2015
Q4
$14.6M Sell
842,421
-109,425
-11% -$1.74M 0.04% 437
2015
Q3
$12.8M Sell
951,846
-7,405
-0.8% -$149K 0.03% 467
2015
Q2
$21.7M Sell
959,251
-424,931
-31% -$7.47M 0.05% 330
2015
Q1
$19.8M Sell
1,384,182
-220,100
-14% -$3.17M 0.04% 370
2014
Q4
$15.5M Buy
1,604,282
+211,200
+15% +$1.88M 0.03% 447
2014
Q3
$12.7M Buy
1,393,082
+375,500
+37% +$3.58M 0.03% 504
2014
Q2
$10.1M Buy
1,017,582
+426,400
+72% +$3.62M 0.02% 608
2014
Q1
$7.51M Buy
591,182
+530,400
+873% +$7.87M 0.02% 674
2013
Q4
$911K Hold
60,782
﹤0.01% 1521
2013
Q3
$671K Hold
60,782
﹤0.01% 1678
2013
Q2
$483K Buy
+60,782
New +$387K ﹤0.01% 1860

Other funds holding HALO

VOYA Investment Management's HALO Position: Q1 2026 in Review

VOYA Investment Management reduced its Halozyme (HALO) stake by 0.14% in Q1 2026, selling an estimated $3.52K and leaving 36,818 shares worth $2.38M. The position accounts for ﹤0.01% of the portfolio, ranked #1109.

VOYA Investment Management first reported a position in HALO in Q2 2013 and has held it in 52 quarters since. The position peaked at $30M in Q1 2025. 634 funds tracked by Wall St. Rank hold HALO as of Q1 2026.

  • VOYA Investment Management held 36,818 shares of Halozyme worth $2.38M as of Q1 2026.
  • VOYA Investment Management sold 50 Halozyme shares in Q1 2026, an estimated $3.52K.
  • Halozyme made up ﹤0.01% of VOYA Investment Management's portfolio in Q1 2026, its #1109 holding.
  • VOYA Investment Management first reported a position in Halozyme in Q2 2013 and has held it in 52 quarters since.
  • VOYA Investment Management's Halozyme position peaked at $30M in Q1 2025.
  • 634 funds tracked by Wall St. Rank held Halozyme as of Q1 2026.

Based on VOYA Investment Management's 13F filing for Q1 2026, filed 12 May 2026.